Emerging treatments for classical myeloproliferative neoplasms.

Vannucchi, Alessandro M

Emerging treatments for classical myeloproliferative neoplasms. [electronic resource] - Blood 02 2017 - 693-703 p. digital

Publication Type: Journal Article; Review

1528-0020

10.1182/blood-2016-10-695965 doi


Antineoplastic Agents--therapeutic use
Clinical Trials as Topic
Disease Progression
Gene Expression Regulation, Neoplastic
Histone Deacetylase Inhibitors--therapeutic use
Humans
Interferon-alpha--therapeutic use
Janus Kinase 2--antagonists & inhibitors
Mutation
Nitriles
Polycythemia Vera--drug therapy
Primary Myelofibrosis--drug therapy
Protein Kinase Inhibitors--therapeutic use
Pyrazoles--therapeutic use
Pyrimidines
Quality of Life
Survival Analysis
Thrombocythemia, Essential--drug therapy